External Advisory Board

Fred Bosman (Chairman)
Emeritus professor of Pathology
University Institute of Pathology
Lausanne University Medical Center (CHUV)

Fred Bosman, (1944, the Netherlands), studied Medicine at the University of Leiden (MD 1971), where he also earned his PhD degree (in cytogenetics, 1976) and trained as a pathologist. He was staff pathologist at the University of Leiden (1975-1981), lecturer at the University of Surinam (1974-1975), Professor and chair of Pathology at the Faculty of Medicine of the University of Maastricht (1981-1990) and at the Faculty of Medicine of the Erasmus University in Rotterdam (1990-1995), Director of the University Institute of Pathology and Professor of Pathology at the University Medical Center (CHUV) of Lausanne in Switzerland (1995-2009), now emeritus. He is invited professor at the School of Medicine of the Patan Academy of Health Sciences in Kathmandu (Nepal), at the Medical University of Havana (Cuba), at the Free University in Brussels (Belgium) and at the University of Porto (Portugal). Fred Bosman is Honorary Fellow of the Royal College of Pathologists (UK) and foreign correspondent of the Royal Netherlands Academy of Sciences.
Fred Bosmans research activities (combining diagnostic and experimental pathology) focused on the biology of digestive tract cancer, notably Barret’s esophagus and colorectal cancer, with a strong emphasis on the development of molecular diagnostics. He has written over 350 original publications and over 50 book chapters (H-index 67). He is member of the Editorial Board of 10 international journals in the fields of Pathology and Histochemistry (former Associate Editor of the Journal of Pathology and presently Editor in Chief of Virchows Archiv, The European Journal of Pathology). He was one of the Editors of the Dutch textbook ‘Oncology’ and of the Dutch textbook ‘Pathology’. He is Section Editor ‘Gastro-Intestinal Pathology’ for a new online Textbook ‘Pathobiology of Human Disease’. He is Series-coeditor of the WHO Series ‘Classification of Human Tumours’, the international standard for tumour classification, and co-editor of the Volume on Tumours of the Digestive Tract.


James Kirkpatrick
Chairman of the Institute of Pathology,
University Medical Center, Johannes Gutenberg University
Chairman of the PEPAIR-lab

James Kirkpatrick has a triple doctorate in science and medicine (MD, PhD, DSc) from the Queen’s University of Belfast (N. Ireland) and since 1993 is Professor of Pathology and Chairman of the Institute of Pathology at the University Medical Center of the Johannes Gutenberg University (JGU) in Mainz, Germany.
Previous academic appointments were in pathology at the University of Ulm (1980-1985), Manchester University (1985-1987) and the RWTH Aachen (1987-1993). Since 1996 he is a Fellow of Biomaterials Science & Engineering (FBSE) of the IUS-BSE (International Union of Societies for Biomaterials Science & Engineering), a Fellow of the Royal College of Pathologists (FRCPath), London (since 1997) and an Honorary Professor at the Peking Union Medical College in Beijing and the Sichuan University in Chengdu, China (since 2004). In 2011 he was appointed Guest Professor at the South China University of Technology in Guangzhou, China and in 2012 Visiting Professor at the Nanyang Technological University, Singapore.
He is author/coauthor of 428 publications in peer-reviewed journals and has made more than 1200 presentations to scientific meetings worldwide. In his career he has supervised 88 (completed) doctorate theses (MD/PhD/DDS) at two universities (Aachen, Mainz). He is a former President of both the German Society for Biomaterials (2001-2005) and the European Society for Biomaterials (2002-2007) and received the latter’s premier award (George Winter Award) in 2008. In 2010 he was awarded the Chapman Medal from the Institute of Materials, Minerals & Mining, London, UK for “distinguished research in the field of biomedical materials”. In 2012 Kirkpatrick was awarded the Silver Medal & Haughton Lectureship from the Royal Academy of Medicine in Ireland and the McGowan Institute Distinguished Lectureship, University of Pittsburgh, USA.
He is a former Associate Editor of the Journal of Pathology (2001-2006) and a current Associate Editor of Biomaterials (since 2002), as well as a member of the Editorial Advisory Board of several journals in the biomaterials and regenerative medicine fields. He is a member of the Scientific Advisory Board of a number of research institutes, centres of excellence and companies in biomaterials and regenerative medicine in Europe, as well as the Medical Technology Committee, Federal Ministry of Education & Research in Germany (BMBF) (since 2005) and the German Federal Institute for Drugs & Medical Devices (BfArM)(since 2007). His scientific interests are in endothelial pathobiology, co-culture systems with human cells in three-dimensions on biomaterials for tissue engineering and regenerative medicine applications (especially bone and respiratory tract), and the development of barrier models (lung, brain) to study nanoparticle interactions with cellular systems.


David Huntsman
University of British Columbia
Vancouver General Hospital, The Prostate Research Centre
Director of the DNA Diagnostic Laboratory,
British Columbia Children’s Hospital

David Huntsman is a Professor in the Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology at The University of British Columbia (UBC) and is the Chew Wei Memorial Professor of Gynaecologic Oncology. He is a a Staff Pathologist at the BC Cancer Agency (BCCA), and a Consulting Pathologist at the Vancouver General Hospital (VGH).
Huntsman is currently the Director of the BC multidisciplinary ovarian cancer research team (OvCaRe), Medical Director of the Centre for Translational and Applied Genomics (CTAG) at the BCCA, and co-Director of the Genetic Pathology Evaluation Centre (GPEC) at the Jack Bell Research Centre, VGH.
Huntsman research has led to development of predictive and prognostic tissue based cancer biomarkers for ovarian cancer and a wide variety of other tumour types. His team created a blueprint for subtype specific ovarian cancer control and have been leaders in the application of novel genomics technologies to ovarian cancer. As collaboration is critical in his field, Huntsman happily leads and engages in a wide number of multidisciplinary research groups. Most recently he has been working on the creation of broad based personalized medicine initiative for British Columbia.


James Fawcett
Chairman of the Cambridge Centre for Brain Repair
Reeve Foundation International Research Consortium
on Spinal Cord Injury

James Fawcett runs one of the six labs that form the Reeve Foundation International Research Consortium on Spinal Cord Injury. His lab is located at Addenbrooke’s Hospital at the University of Cambridge, in England, and is part of the Center for Brain Repair, an institute formed in 1995 and funded by the British Medical Research Council.
Fawcett started his career as a doctor, working in the autoimmune disease area, including very tough conditions such as systemic lupus. "One of the things about being a doctor, you eventually become competent at what you are doing. For some people, that's great. Others might feel, 'what's new? I don’t want to do this for 40 years.' I decided I wanted to start doing research." One of Fawcett's options was to stay in the area of autoimmune diseases. "It's is an interesting field and would have been an easy move but at the time, the basic immunology science was not in place to ask sensible questions about how to address autoimmune problems. Indeed, nothing much happened in that field until the immunology caught up with it just five or six years ago."


Reinhard Faessler
Head of the Department of Molecular Medicine
Max Planck Institute of Biochemistry
Martinsried, Germany

Born on September 8, 1956 in Dornbirn, Austria. Study of medicine and MD, University of Innsbruck (1981), resident at various hospitals in Austria and at the Institute for General and Experimental Pathology, University of Innsbruck (1982-1988), postdoc, Whitehead Institute, Cambridge, USA (1988-1992), Group Leader Austrian Academy of Sciences, Salzburg, Austria (1992-1993), Group Leader Max Planck Institute of Biochemistry(1993-1998), Professor and Chair of the Department of Experimental Pathology, Lund University, Sweden (1998-2001), Director and Scientific Member at the Max Planck Institute of Biochemistry(since 2001). For his research Fässler has been honored with the Hermann und Lilly Schilling Professorship (1995) and with the Göran Gustafsson Prize (2001), among other awards. He is honorary professor at the LMU Munich, Univ. of Copenhagen and Univ. of Hong Kong. In 2000 he was elected member of EMBO and in 2008 he became a corresponding member of the Austrian Academy of Sciences.


Erich Nigg
Director and Professor of Cell Biology
Biozentrum of University of Basel, Switzerland


Erich Nigg is a cell biologist who originally trained as a biochemist. During his scientific career he moved between different fields, countries and cultures, and always found the experience of change rewarding and highly stimulating.
Erich Nigg was educated in Switzerland and studied Life Sciences at the ETH in Zurich. He completed his PhD in 1980 focusing on the mobility of membrane proteins. He then continued his research at the University of California in San Diego, U.S.A., where he investigated the influence of oncogenic protein kinases on the cytoskeleton.
Subsequently, he worked at several institutions throughout Switzerland, notably the ETH, the Swiss Institute for Experimental Cancer Research (ISREC) and the University of Geneva, before he joined the Max Planck Society in Germany. His studies encompassed many fields, primarily the structure and dynamics of the nuclear envelope, the mechanisms underlying signal transduction from the plasma membrane to the cell nucleus, and the regulation of the cell cycle. At present, the research in his laboratory aims at elucidating the molecular mechanisms that control chromosome segregation during cell division and the centrosome duplication cycle. Disruption of these processes are widely thought to contribute to the chromosomal instability of tumour cells.
Since February 2009 Erich Nigg is the director of the Biozentrum of the University of Basel, one of the most prestigous Life Science research and teaching institutions in Switzerland. Erich Nigg was awarded several prizes and is an elected member of the German Academy of Sciences, the European Molecular Biology Organization (EMBO), the Academia Europeae, as well as the the European Academy of Cancer Sciences.


Jean-Pierre Gorvel
Centre d'Immunologie de Marseille-Luminy


Jean-Pierre Gorvel is a trained Cellular microbiologist with a unique experience at the frontier of Cell Biology, Microbiology and Immunology. He is a leader in studies of Brucella and Salmonella pathogenicity. In Marseille, France, his research is centered on combating Infectious diseases by studying host/pathogen interactions and vaccine design.
As a PhD student, he applied for the first time flow cytometry to organelle sorting.Then, he is the one who has discovered first the function of Rab small GTPases in endocytosis when he was a research associate at the EMBL in Heidelberg, Germany. In 1992, he became group leader at the Centre d'Immunologie de Marseille-Luminy (CIML), one of the major places in Europe for Immunology Research. He introduced and promoted Infectious diseases at CIML and became the Director in 2006. At the same time he became the director of a group of experts in bioterrorism in France and at the European Union. As a specialist of bacterial pathogenesis, he is the one who characterized the replication niche of Brucella and also identified host partners of Salmonella effectors secreted by the type III secretion system. Five years ago, he started collaborating with the Baylor Institute for Immunology Research in Dallas to improve knowledge on dendritic cell function in human diseases such as hepatitis and tuberculosis. Since then, he is directing a group of twenty researchers in France, all involved in bacterial pathogenesis and immunity against microbial infections. He was given awards from the French Academy of Sciences in 2007 and from the French Foundation of Medical research in 2010 for his career in Infectious diseases. He is also a member of the American Academy of Microbiology.